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Medication error (ME) is the most common single preventable cause of adverse drug events which negatively
affects patient safety. ME prevalence is a valuable safety indicator in healthcare system. Inadequate studies on ME,
shortage of high-quality studies and wide variations in estimations from developing countries including Iran,
decreases the reliability of ME evaluations. In order to clarify the status of MEs, we aimed to review current available
literature on this subject from Iran. We searched Scopus, Web of Science, PubMed, CINAHL, EBSCOHOST and also
Persian databases (IranMedex, and SID) up to October 2012 to find studies on adults and children about
prescription, transcription, dispensing, and administration errors. Two authors independently selected and one of
them reviewed and extracted data for types, definitions and severity of MEs. The results were classified based on
different stages of drug delivery process. Eighteen articles (11 Persian and 7 English) were included in our review.
All study designs were cross-sectional and conducted in hospital settings. Nursing staff and students were the most
frequent populations under observation (12 studies; 66.7%). Most of studies did not report the overall frequency of
MEs aside from ME types. Most of studies (15; 83.3%) reported prevalence of administration errors between
14.3%-70.0%. Prescribing error prevalence ranged from 29.8%-47.8%. The prevalence of dispensing and transcribing
errors were from 11.3%-33.6% and 10.0%-51.8% respectively. We did not find any follow up or repeated studies.
Only three studies reported findings on severity of MEs. The most reported types of and the highest percentages
for any type of ME in Iran were administration errors. Studying ME in Iran is a new area considering the duration
and number of publications. Wide ranges of estimations for MEs in different stages may be because of the poor
quality of studies with diversity in definitions, methods, and populations. For gaining better insights into ME in Iran,
we suggest studying sources, underreporting of, and preventive measures for MEs.
Keyword: Medication errors, Drug use errors, Patient safety, Prescribing, Transcribing, Drug administration,
Dispensing, Pharmacists, Nursing staff, IranBackground
Medication error (ME), as a universal problem [1], is
one of the most common types of medical errors [2,3]. It
is also the most common single preventable cause of
adverse drug events [4].
ME is defined as “any preventable event that may cause
or lead to inappropriate medication use or patient harm
while the medication is in the control of the health care pro-
fessional, patient, or consumer.” (US National Coordinating* Correspondence: hajibaba@tums.ac.ir
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reproduction in any medium, provided the orCouncil for Medication Error Reporting and Prevention:
NCC MERP) [5]. MEs may cause serious consequences
which affect millions of patients every year [6] including
death, disability, prolonged hospitalization, and also physical
and psychological harm [7]. Thus, not only they can be
costly, which ultimately affect the whole society [6], but also
they can negatively influence patient safety [3,7]. Prevalence
of MEs and its potential harm to patients make them valu-
able safety indicators in hospitals and healthcare system
which should be reported and analyzed reliably [8].
As medication process has different stages, various
estimations of error prevalence have been provided by
researchers and evaluators worldwide. For example,
the UK’s National Patient Safety Agency has reportedal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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dispensing, and 16% in prescribing stages. Moreover,
the most serious incidents caused by errors happen
41% in administration and 32% in prescribing stages
[9]. The US Agency for Healthcare Research and Quality
(AHRQ) has reported that 20% of medical errors which
lead to death or injury are from MEs [10].
It is hard to determine the actual prevalence of medica-
tion errors [8] because of the extensive variations in the
reported incidence [11,12] and ME categorization [12].
Universally, lack of established definitions [12,13] along
with different methods and criteria for measurement of
MEs [13], affect the reliability of assessments in different
settings [2,12] and countries [12] which provides incom-
plete image of the actual prevalence of MEs [13].
Establishing a system based on spontaneous and volun-
tary reporting is essential for drug safety surveillance [14].
Nevertheless, there is no established active continuous
reporting system for MEs in Iran. Furthermore, shortage
of consistent assessment reports is another challenge for
quantifying the status of ME.
In developing countries, inadequate studies on ME,
shortage of high-quality studies with well-designed
methodologies in addition to wide variations in reported
ME, add to difficulties in providing reliable evaluations for
MEs [1]. Iran, like other developing countries, is vulnerable
to unreliable assessments for MEs [3].
Even though, we know that some studies have been
conducted with abovementioned limitations and challenges
in our country, but in order to clarify the incidence and
types of MEs thoroughly, we aimed to identify and review
current available published studies on this subject.
Methods
Databases
In order to review Persian and English language-literature
on medication errors in Iran, we searched these English
electronic databases to find articles related to errors in
prescription, transcription, dispensing, and administration:
Scopus, Web of Science, PubMed, the Cumulative Index
to Nursing & Allied Health Literature (CINAHL), and
EBSCOHOST. We searched these Persian electronic
databases: IranMedex, and Scientific Information Database
(SID). We also manually searched references within articles
to identify additional original papers. The time span was up
to October 2012.
Search terms
We used these English terms and their corresponding
Persian equivalents: administration error(s), administration
mistake(s), dispensing error(s), dispensing mistake(s), docu-
mentation error(s), drug mistake(s), medication error(s),
medication mistake(s), nurse(s), pharmacist(s), physician(s),
prescribing error(s), prescribing mistake(s), transcribingerror(s), transcribing mistake(s), wrong calculation(s), wrong
dose(s), wrong drug(s), wrong medication(s), and wrong
route(s) of administration. Each of the words were com-
bined using “OR” and then combined using “AND” with
(Iran OR Iranian OR I.R.Iran).
Inclusion/exclusion criteria
We considered all types of original studies on adults and
children; i.e., clinical trials, longitudinal, cohort, case–
control, and cross-sectional studies. We looked for
studies which reported types, definitions and severity of
MEs. Letters, case reports, conference papers, organizational
reports, opinions or editorial papers were excluded. We also
excluded articles focused on medical (not medication)
errors and nursing practice errors. Moreover, we elimi-
nated articles on preventive measures which were solely
focused on usability and acceptability of measures, not
on the outcome of ME.
Selection, reading and information extraction
Two authors independently selected and one of them
reviewed the articles by following these stages:
Inclusion and exclusion criteria were assessed both in
reading the titles and abstracts of our search results.
The data extraction tables were completed for each
article using these characteristics: types; unit of observa-
tion; sample size; study design and/or measurement tool;
reported outcomes; main findings; language; ME defini-
tions; specific types of ME definition; specialty of data
collectors and corresponding authors. Then we found
all full-texts of the articles selected and the exclusion
criteria were also applied to the full-texts.
We classified the results from studies on types of MEs
using “types of drug errors per stage of the drug delivery
process” proposed by Allard et al. in 2002 [15]. Allard et al.
has proposed prescribing, transcribing, dispensing and
administration stages in the drug delivery process.
We considered the results reported by more than 30%
of studies in every category as the most frequent topics. We
report the error prevalence in different units of observa-
tions based on their most frequent percentages.
Results
Search results
Initially, 122 and 88 studies were identified in English and
Persian biomedical databases respectively, after removing
the duplicates. Of the 210 studies, 177 were of no relevance
to the current review according to their titles and abstracts.
Seven studies did not meet the inclusion criteria according
to their full-text. After hand-searching of the reference lists
of all primary studies, we added another 4 studies; this left
us with 30 eligible studies for review. Out of 30 studies, 18
assessed types of medication errors. Figure 1 summarizes
the complete process of selection.
Records identified in
English language databases
(n= 179)
Records identified in
Persian language databases
(n= 138)
Records after removal
of duplicates
(n= 88)
Records screened by
title and abstract
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searching of references
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Full-text articles
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Figure 1 Search process and number of eligible studies.
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The time span of studies was from 2006 onwards. Other
characteristics of studies on medication error included
in our final review with their most frequent topics covered
are summarized in Table 1.
Eleven studies (61.1%) have been written in Persian
and only 7 (38.9%) were in English. All study designs were
cross-sectional and conducted in hospital settings. NearlyTable 1 Characteristics of studies on types of MEs with their m
# of studies Publication years Units of observation (# of studies)
Nursing Students: 5
Nursing staff: 5
Patients’ medical charts: 4
18 2006–2012 Dose administration by nurses: 2
Infusion Pumps: 1
Midwives: 1
* A few studies included more than one units of observation. So, the total units of o
** Topics which had been covered in over 30% of studies were mentioned as mosthalf of the studies (8 out of 18) used questionnaires for data
gathering whereas 5 out of 18 studies used direct observa-
tion. Nursing staff and nursing students were the most
frequent populations under observation (12 studies; 66.7%).
The most common population introduced as correspond-
ing authors was from the nursing staff (10 studies; 55.5%)
followed by clinical pharmacists (6; 38.9%). Detailed
characteristics of studies on types of medication aboutost frequent topics covered
* Study designs Most frequent topics covered (# of studies) **
Administration: 15
Wrong dose: 9
Wrong infusion rate: 7
Wrong medication: 5
Wrong time: 5
Prescribing: 6
Wrong dose: 5
Cross-sectional Wrong medication:4
Wrong rout : 2
Wrong frequency: 2
Dispensing: 5
Wrong dose: 3
Inappropriate diluents: 2
Transcribing: 3
Unauthorized medication: 2
bservations may surpass the total number of studies.
frequent.
Mansouri et al. DARU Journal of Pharmaceutical Sciences 2013, 21:49 Page 4 of 10
http://www.darujps.com/content/21/1/49their definitions, data collectors and corresponding authors
are presented in Table 2.
Many studies reported frequencies for ME types sep-
arately for different categories (prescribing, transcribing,
dispensing, and administration) and most of them did
not report the overall frequency of MEs aside from ME
types. All studies reported the frequency of each type of
MEs as percentages (Table 3).
Medication error definitions
Eleven studies provided their definitions for MEs; but,
they used different definitions. Eight out of 18 studies used
NCC MERP definition, 2 studies used their own modified
definitions and 1 of them used AHSP (American Society
of Health-System Pharmacists) definition. ME definitions
were not clear or defined in the remaining 7 studies.
Specific definition for types of medication errors detected
was provided by only five studies (27.8%); others used gen-
eral definitions or no definition. All the five studies have
been done by clinical pharmacists. Of the 15 studies on
administration error, only 2 (13.33%) provided specific
definitions for administration errors [20,32]. Three studies
out of 6 (50%) on prescribing error used specific definitions
[16,20,22]. Definitions for transcribing error were provided
in two out of 3 studies (66.7%) [25,32]. No specific defin-
ition was mentioned in studies on dispensing errors.Table 2 Detailed characteristics of studies on types of MEs’ d
Author(s)/Year Language MEdefinitions
Specif
ME d
1 [16] Mousavi M, et al. 2012 E Modified Prescrib
2 [17] Vazin A, et al. 2012 E NCCMERP
3 [18] Cheraghi MA, et al. 2012 P NA
4 [19] Ebrahimi Rigi Tanha Z,
et al. 2012
P NA
5 [20] Khalili H, et al. 2011 E NCCMERP Admini
prescrib
6 [21] Zahmatkeshan N, et al. 2010 P NA
7 [22] Vessal G. 2010 E ASHP Prescrib
8 [23] Mohammadnejad E, et al. 2010 P Modified
9 [24] Mohsenzade A, et al. 2010 P NCCMERP
10 [25] Fahimi F, et al. 2009 E NCCMERP Transcrib
11 [26] Nikpeyma N, et al. 2009 P NCCMERP
12 [27] Baghcheghi N, et al. 2008 P NA
13 [28] Fahimi F, et al. 2008 E NCCMERP
14 [29] Koohestani HR, et al. 2008 P NA
15 [30] Koohestani HR, et al. 2008 P NA
16 [31] Vallizade F, et al. 2008 P NA NC
17 [32] Fahimi F, et al. 2007 E NCCMERP Presc
Transcrib
18 [33] Penjvini S, et al. 2006 P NA
E: English, P: Persian, NA: not available, def: definition.Administration errors
Most of studies (15 of 18 studies; 83.3%) reported adminis-
tration errors with reported prevalence between 14.3% and
70.0% in administration stage.
Overall estimations for administration errors based
on different units of observation were as follow; 61.0%
to 70.0% in administered doses, 32.4% in pediatric
medical charts, 27.0% to 44.7% in nursing staff, 20.6%
to 28.6% in nursing students, and finally 14.3% in adult
medical charts.
In administration stage, wrong medication was reported
only in nursing students (14.28-27.7%) and wrong time
only in nurses (10.0- 18.0%). Wrong rate of injection was
reported in three studies by nurses; only one out of these
three studies reported estimation for the error prevalence
(44.7%). Wrong rate of injection was reported in four
studies by nursing students; all of them reported estima-
tion for the error prevalence between 11.5% and 28.7%. In
comparison, wrong dose error prevalence in administra-
tion was higher in nursing students (17.4%-37.7%) than
nurses (7.7%-27%).
Prescribing errors
Thirty three percent of studies reported prescribing errors
and the error prevalence ranged from 29.8% to 47.8% in
different studies.efinitions, data collectors and corresponding authors
ic types of
efinition Data collectors Corresponding author
ing error def Clinical pharmacist Clinical pharmacist
NA Pharmacist Clinical pharmacist
NA NA Nursing residency student
NA NA Nursing group
stration and
ing error def.
Clinical pharmacist Clinical pharmacist
NA NA Nursing group
ing error def. Clinical pharmacist Clinical pharmacist
NA NA MS in nursing
NA NA MD, Associate professor
ing error def. NA Clinical pharmacist
NA NA MS in nursing
NA MS in nursing MS in nursing
NA Pharmacist Clinical pharmacist
NA NA Senior lecturer in nursing
(instructor)
NA NA MS in nursing
CMERP NA Instructor of Pediatric Nursing
ribing and
ing error def.
clinical pharmacy resident Clinical pharmacist
NA NA Nursing instructor
Table 3 Detailed characteristics of studies on types of medication error with their most frequent findings
Author(s)/Year Unit of observation Sample
size
Study design/
Detecting method
Types of medication errors
(in descending order)
Findings
1 [16] Mousavi M,
et al. 2012
Patients 450 Cross-sectional;
Medical record
Prescribing
− Wrong rate [of IV fluid administration] 29.8%
− Wrong dose [volume of fluid] 26.5%
− Wrong medication [type of fluid] 24.6%
2 [17] Vazin A,
et al. 2012
Administered doses
by nurses
307 Cross-sectional;
Direct Observation
Prescribing 35.1%
− Monitoring § 9.5%
− Wrong medication 7.4%
− Wrong dosage form 6.8%
− Wrong dose 5.9%
Administration 61.0%
− Wrong technique § 20.4%
− Wrong time 10.0%
− Wrong preparation 10.0%
− Wrong dose 7.7%
3 [18] Cheraghi MA,
et al. 2012
Nurses 64 Cross-sectional;
self report survey
(Questionnaire)
Administration
− Wrong [infusion] rate 44.7%
− Wrong dose 23.4%
4 [19] Ebrahimi Rigi
Tanha Z, et al. 2012
Nursing students 54 Cross-sectional;
self report survey
(Questionnaire)
Dispensing and/or preparation
− Wrong concentration 33.4%
− Wrong volume 25.9%
− Wrong dose 22.2%
Administration
− Wrong time 20.6%
− Failing to check [oral] medication- food interaction 14.7%
− Omission 11.4%
5 [20] Khalili H,
et al. 2011
Medical charts 861 Cross-sectional;
Chart review
Prescribing
− Wrong dose 38.4%
− Wrong medication 33.0%
Administration
− Omission [Medication not taken/administered at all] 14.3%
− Wrong medication 5.4%
6 [21] Zahmatkeshan N,
et al. 2010
Nursing staff;
Midwives
332 Cross-sectional;
self report survey
(Questionnaire)
Administration
68 − Wrong dose 37.7%
− Wrong medication 27.7%
− Wrong route 18.3%
7 [22] Vessal G. 2010 Patients 818 Cross-sectional;
Chart review
Prescribing
− Wrong frequency 37.2%
− Wrong medication 19.8%
− Wrong dose 16.3%
8 [23] Mohammadnejad E,
et al. 2010
Nursing students 78 Cross-sectional;
self report survey
(Questionnaire)
Administration
− Wrong dose 24.3%
− Wrong medication 18.9%
− Wrong [infusion] rate 16.2%
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Table 3 Detailed characteristics of studies on types of medication error with their most frequent findings (Continued)
9 [24] Mohsenzade A,
et al. 2010
Pediatrics’
medical charts
2250 Cross-sectional;
Medical records
Prescribing 46.3%
− Wrong dose 37.0%
− Wrong frequency 28.0%
− Wrong route 19.0%
Transcribing 10.0%
Dispensing 11.3%
Administration 32.4%
10 [25] Fahimi F,
et al. 2009
Pediatrics’
medical charts
287 Cross-sectional;
Direct observation
Transcription 51.8%
− Omission 52.0%
− Wrong dose 18.0%
− Unauthorized medication* 16.0%
− Replacing medication without physician’s approval 7.0%
− Requesting more than required according to order 7%
11 [26] Nikpeyma N,
et al. 2009
Nurses 100 Cross-sectional;
self report survey
(Questionnaire)
Administration
− Wrong dose 27%
− Omission 22%
− Wrong time 18%
12 [27] Baghcheghi N,
et al. 2008
Nursing students 372 Cross-sectional;
Direct observation
Dispensing and/or preparation 13.4%
− Inappropriate diluents 2.7%
− Forgetting to prepare medication 2.2%
− Wrong dose 1.9%
Administration 27.8%
− Wrong [bolus] rate 11.6%
− Wrong [IV injection] rate 9.1%
− Wrong route [of injection] 3.2%
13 [28] Fahimi F,
et al. 2008
IV injections
administered
by nurses
524 Cross-sectional;
Direct observation
Dispensing and/or preparation 33.6%
− Wrong dose
− Inappropriate diluents
− Inappropriate storage
Administration 66.4 %
− Wrong [bolus] rate
− Wrong [infusion] rate
14 [29] Koohestani HR,
et al. 2008
Nursing students 76 Cross-sectional;
self report survey
(Questionnaire)
Administration
− Wrong dose 22.0%
− Wrong medication 20.3%
− Wrong [infusion] rate 18.6%
15 [30] Koohestani HR,
et al. 2008
Nursing students 60 Cross-sectional;
self report survey
(Questionnaire)
Administration
− Wrong [infusion] rate 28.6%
− Wrong dose 17.1%
− Wrong medication 14.3%
16 [31] Vallizade F,
et al. 2008
Pediatrics’
medical charts
898 Cross-sectional;
Medical records
Prescribing
− Not highlighting administration
considerations §
74.1%
− Wrong time 47.8%
− Illegible or ambiguous handwriting 45.5%
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Table 3 Detailed characteristics of studies on types of medication error with their most frequent findings (Continued)
Administration
− Not pursuing administration considerations § 77.5%
− Failing to check interactions 14.9%
− Wrong time 14.8%
17 [32] Fahimi F,
et al. 2007
Infusion pump doses 43 Cross-sectional;
Direct observation
Transcribing
− Unauthorized medication 10%
Administration
− Wrong dose and rate 70%
Dispensing
− Inappropriate labeling 20.0%
18 [33] Penjvini S,
et al. 2006
Nursing staff 104 Cross-sectional self
report survey
(Questionnaire)
Administration
− Omission 42.5%
− Wrong dose 15.1%
− Wrong time 13.7%
* Unauthorized medication: those medications that were administered but could not be found in physician’s orders.
§ Vazin and Delfani, have categorized “wrong technique” and “monitoring” under administration and prescribing respectively [17]. Vallizade et al. also have
categorized “Not pursuing administration considerations” and “Not highlighting administration considerations” under administration and prescribing respectively
[31]. These categorizations are not in accordance with our classification based on the article by Carthey [15].
IV: Intravenous; IM: Intramuscular.
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on their units of observations; 38.4% to 47.8% in medical
charts, 29.8% to 37.2% in patients, and 35.1% in adminis-
tered doses.
Most of the studies which reported errors in prescription
stage were conducted by clinical pharmacists. Five out of 6
studies in this category used medical records or chart re-
views as the error detection method. Only 1 of them used
direct observation for measuring errors in prescription.
Wrong dose prevalence in prescribing stage varied from
5.9 to 37.0%, and wrong medication ranged between 7.4
and 33.0% in different studies.
The lowest prescribing error prevalence was reported
in the study conducted by clinical pharmacist who used
direct observation as error detection method [17]. The
highest prescribing error prevalence was reported in the
study conducted on pediatrics medical records, while
none of the most common types of prescribing errors
were reported in the last study [31].
Dispensing errors
The prevalence of dispensing errors was assessed by 5
studies and differed from 11.3% to 33.6%. It was also
variable in different units of observation; 33.6% in
administered doses, 20.0% in infusion pump doses, 13.4%
in nursing students and 11.3% in medical charts.
Dispensing errors were detected by direct observation
(3 studies), questionnaire (1 study) and medical records
(1 study).
Wrong dose error in dispensing stage ranged between
1.9% and 2.7%. The lowest prevalence of dispensingerror was detected in the study which used direct ob-
servation [27].
Transcribing errors
Transcribing errors was assessed in three studies. The
prevalence of this type of error was between 10.0% and
51.8% in pediatric medical charts; another study estimated
transcribing errors as 10.0% for infusion pump doses.
The most frequently reported transcribing error was
unauthorized medication which varied between 10.0%
and 16.0% in two studies.
Two studies used direct observation and one used
medical records review for detecting transcribing errors.
Severity of MEs
Three studies reported findings on severity of MEs
[16,22,32]. For categorizing MEs and determining the
severity of them, 2 studies used National Coordinating
Council for Medication Error Reporting and Prevention
(NCC MERP) Index [16,32]; the other one used defini-
tions and leveling provided by Hartwig, Denger, and
Schneider [22].
Fahimi et al. assessed the severity of errors in prepar-
ation and administration of medications by infusion de-
vices; they reported that labeling errors, unauthorized
medications, and rate-concentration inconsistencies all
belonged to category B [32]. Mousavi et al. investigated
fluid therapy errors in medical wards; they found that
the most common type of error was wrong rate of fluid
administration (29.8%) in severity categories D (45.5%),
C (44.8%), and E (7.9%) [16].
Mansouri et al. DARU Journal of Pharmaceutical Sciences 2013, 21:49 Page 8 of 10
http://www.darujps.com/content/21/1/49In the study on prescribing errors in nephrology wards,
Vessal reported level 1 as the most common severity cat-
egory (77 observed errors; 89.5% of all), in which errors
had occurred but had not resulted harm to patients [22].
Discussion
The aim of our study was to clarify the incidence and
types of medication errors by reviewing current available
literature on MEs in Iran. Our findings show that the
most reported type of ME and highest percentage for
any type of error is in the administration error stage.
Studies characteristics
All studies in our review had been conducted after 2005.
This shows that studying MEs in Iran is a relatively new
area of research considering the duration of only six
years for active publication. Research on ME has started
since 1960 and grew steadily from 1990 onwards [34].
The first published studies included in different reviews
of the literature date back to 1984–1985 [12,35]. But,
in two reviews by Lewis et al. [35] and Lisby et al. [12],
most included studies were done after 2000 and between
2005 and 2006 respectively.
We found 18 studies which assessed types of MEs.
But, in a systematic review by Alsulami et al. 10 related
studies included from Iran related to types of MEs [1].
This difference in the included articles may be due to the
language bias because many of the articles were in Persian
and had been translated [1]; in our study, only 7 out of 18
articles were in English. Moreover the quality assessment
by Alsulami et al. was an additional value-added step in
comparison to our review; this may have caused dropping
off those studies with lower quality in their study.
In order to provide a comprehensive estimation of the
prevalence of MEs, the ideal approach is using multiple
error detection methods all together which maximizes
probability of error detection in every stage of the medica-
tion process [11,35,36]. But, none of our included studies
used multiple error detection methods concurrently and
their estimates just relied on one (usually non-overlapping)
error detection method.
Additionally, follow-up studies are required to evaluate
the status of MEs in depth [7]; but we did not find any
follow-up or repeated study whit the same settings in
the 6 years time frame. Moreover, there is a huge shortage
of interventional studies with specific focus on decreasing
prevalence of medication errors. Recently, protocols of
randomized controlled trials have been published to assess
the effectiveness of audit and feedback on physician
prescribing [37].
Medication error definitions
We found that, ME definitions were different from one
study to another [12,36]. Most studies (45%) used theNCC MERP general definition for ME ; this figure is
close to 38% reported in the systematic review by Lisby
et al. [12]. Nearly 50% of our studies which reported
prescribing errors used specific definitions in compari-
son to 38% of studies included in the review of Middle
Eastern studies by Alsulami et al. [1]. Just above 13% of
our studies used specific definitions for administration
errors in comparison to 27% reported in the systematic
review by Alsulami et al. in the Middle East [1]. In order
for error prevalence to be comparable, the definitions
used in different studies should be as similar as possible
[38]. But, regarding the fact that there is no standard
definition available for ME [38], inconsistencies in ME
assessment inevitably occur. This is in agreement with
the findings reported by Lisby et al. [12].
Overall typology of ME
Wrong dose or error in dosage was the most commonly
reported type of errors regardless of medication process.
This finding is in accordance with many other studies as
well [1,12,15,35,39,40]. It seems that the prevalence of
wrong dose errors in our study (2% to 38%) -although
wide- is pretty close to the Middle Eastern countries
(0.15% -35%) [1].
In Iranian studies the most reported types of MEs were
wrong dose followed by wrong intravenous (IV) administra-
tion rate (infusion or bolus), wrong medication, wrong time
and omission. These types can be found in other reviews as
the most frequent errors [1,10,15,35,36,40,41], except for
the wrong rate of IV injections.
Administration errors
The most frequent reported type of ME in our studies
was administration error. This is in contrast to other
reviews that stated the majority of MEs have occurred in
the prescribing stage [1,34,36]. This finding might have
been because most of our studies had been performed
by nursing groups involved in administration -not pre-
scribing - of medications.
Regardless of the unit of observation in our studies,
administration errors had highest percentage of preva-
lence in all stages of medication process followed by
prescribing errors. Error prevalence in administration
stage in our study (14.3%-70%) is somehow close to the
other Middle Eastern countries (9.4%- 80%) [1]. Adminis-
tration errors, although with lower prevalence than ours,
has also been the most common type of MEs in developed
countries (47%) [10].
Most studies which reported administration errors
used nurse-completed questionnaires as their only
data gathering tool. But, using questionnaires is not
recommended as the main data gathering tool to evaluate
types of ME [10,12,35,36]. The main reason is that it
cannot determine the prevalence of MEs due to the lack
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able denominators [36]. It has been suggested to consider
using questionnaires as an additional tool along with other
data gathering methods [35]. In contrast, direct observa-
tion, as the second most popular data gathering method
in our studies, is considered to be the most sensitive way
of detecting administration errors [12].
Medical record or chart reviews were used infrequently
in Iranian studies, some authors have stated that these
tools can lead to underestimation of administration errors
[12,35].
Prescribing errors
Prescribing errors were the second most common type
of ME in our studies. This is not in accordance to many
other studies which accounted prescribing errors as their
first most frequent type of ME [10,11,15,35,36]. The upper
limit of prescribing errors prevalence in our study (29.7%-
47.8%) is much lower than the reported figures in the
Middle Eastern countries (7.1%-90.5%) and higher than
reported by high-income countries like UK (2-14%) [1].
Nevertheless, inappropriate physician prescribing has been
shown to provide major concerns in clinical settings [37].
Lewis et al., which included only studies on prescrib-
ing errors, showed that the majority of data collectors
were pharmacists [35]. Detection of prescribing errors is
usually done by pharmacists or clinical pharmacists, es-
pecially in the hospital settings [16,20,22]. But, currently
there are just few practicing clinical pharmacists in Iranian
hospitals and medical wards [20]. This can be one of
the future orientations for research and development
in ME management.
In Iranian studies, three data gathering method were
used for detecting prescribing errors; medical records
review, chart review and direct observation. Based on the
evidence, chart review is the most appropriate method for
detecting of prescribing errors [35,36]. Medical records
review has higher rates of error detection, but it is prone to
biases imposed from incomplete documentation [35].
Dispensing errors
The prevalence of dispensing errors in our studies varied
between 11.3% and 33.6%; this is higher than the reported
figures in other studies [15,42]. But, in one systematic
review on dispensing errors in pediatric wards, the esti-
mated prevalence varied between 5% and 58% [36], which
is much wider than situation in Iran. We encountered the
shortage of studies that provided information about this
stage of the medication process, both in our studies and
also in other reviews.
Transcribing errors
The prevalence of transcribing errors in our studies varied
between 10.0% and 51.8%; this is also higher than thereported figures in other studies [15,42]. Alsulami et al.
included just one study on transcribing errors [1], which we
reviewed the same study as well. The shortage of studies on
this stage of medication process is a major challenge in
providing precise estimation of transcribing errors.
Severity of MEs
We found only three studies that reported severity of MEs
and Alsulami et al. included only one [1]. This shows
the shortage of evidence on outcomes of MEs in Iran,
and accordingly the serious lack of monitoring and
analyzing the adverse outcome of these errors in Iran.
Conclusion
The aim of this review was to evaluate the status of MEs in
Iran according to available published evidence. We encoun-
tered wide ranges of estimations for MEs in different stages
mostly because of the poor quality of studies with diversity
in definitions, methods, and populations. Although, the
comparison of ME estimations is difficult, the reported
prevalence of errors is higher than other countries.
At last, for gaining a more comprehensive insight into
ME in Iran, we propose studying sources, underreporting
of, and preventive measures for MEs.
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